Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
Authors:
- René J van der SchaafRSRené J van der Schaaf
- Bimmer E ClaessenBCBimmer E Claessen
- Loes P HoebersLHLoes P Hoebers
- Niels J VeroudenNVNiels J Verouden
- Jacques J KoolenJKJacques J Koolen
- Maarten J SuttorpMSMaarten J Suttorp
- Emanuele BarbatoEBEmanuele Barbato
- Matthijs BaxMBMatthijs Bax
- Bradley H StraussBSBradley H Strauss
- Göran K OlivecronaGOGöran K Olivecrona
- Vegard TusethVTVegard Tuseth
- Dietmar GlogarDGDietmar Glogar
Open Access
- 21 September 2010
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 11 (1) , 89
Abstract
Background: In the setting of primary percutaneous coronary intervention, patients with a chronic total occlusion in a non-infarct related artery were recently identified as a high-risk subgroup. It is unclear whether ST-elevation myocardial infarction patients with a chronic total occlusion in a non-infarct related artery should undergo additional percutaneous coronary intervention of the chronic total occlusion on top of optimal medical therapy shortly after primary percutaneous coronary intervention. Possible beneficial effects include reduction in adverse left ventricular remodeling and preservation of global left ventricular function and improved clinical outcome during future coronary events. Methods/Design: The Evaluating Xience V and left ventricular function in Percutaneous coronary intervention on occLusiOns afteR ST-Elevation myocardial infarction (EXPLORE) trial is a randomized, prospective, multicenter, two-arm trial with blinded evaluation of endpoints. Three hundred patients after primary percutaneous coronary intervention for ST-elevation myocardial infarction with a chronic total occlusion in a non-infarct related artery are randomized to either elective percutaneous coronary intervention of the chronic total occlusion within seven days or standard medical treatment. When assigned to the invasive arm, an everolimus-eluting coronary stent is used. Primary endpoints are left ventricular ejection fraction and left ventricular end-diastolic volume assessed by cardiac Magnetic Resonance Imaging at four months. Clinical follow-up will continue until five years. Discussion: The ongoing EXPLORE trial is the first randomized clinical trial powered to investigate whether recanalization of a chronic total occlusion in a non-infarct related artery after primary percutaneous coronary intervention for ST-elevation myocardial infarction results in a better preserved residual left ventricular ejection fraction, reduced end-diastolic volume and enhanced clinical outcome. Trial registration: trialregister.nl NTR1108.Keywords
This publication has 29 references indexed in Scilit:
- Effect of Multivessel Coronary Disease With or Without Concurrent Chronic Total Occlusion on One-Year Mortality in Patients Treated With Primary Percutaneous Coronary Intervention for Cardiogenic ShockThe American Journal of Cardiology, 2010
- Evaluation of Left Ventricular Function Three Years After Percutaneous Recanalization of Chronic Total Coronary OcclusionsThe American Journal of Cardiology, 2008
- Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary interventionAmerican Heart Journal, 2007
- Impact of Multivessel Coronary Disease on Long-Term Mortality in Patients With ST-Elevation Myocardial Infarction Is Due to the Presence of a Chronic Total OcclusionThe American Journal of Cardiology, 2006
- Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapyHeart, 2006
- In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarctionThe American Journal of Cardiology, 2005
- Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarctionAmerican Heart Journal, 2004
- Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) StudyInternational Journal of Cardiovascular Interventions, 2004
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- Effect of late percutaneous angioplastic recanalization of total coronary artery occlusion on left ventricular remodeling, ejection fraction, and regional wall motionThe American Journal of Cardiology, 1996